TIP 28: Naltrexone And Alcoholism Treatment
... clinical, research, and administrative experts to produce the TIPs, which are distributed to a growing number of facilities and individuals across the country. The audience for the TIPs is expanding beyond public and private substance abuse treatment facilities as alcohol and other substance abuse d ...
... clinical, research, and administrative experts to produce the TIPs, which are distributed to a growing number of facilities and individuals across the country. The audience for the TIPs is expanding beyond public and private substance abuse treatment facilities as alcohol and other substance abuse d ...
Drug Class Review on Constipation Drugs
... Gartlehner G, Jonas DE, Morgan LC, Ringel Y, Hansen RA, Bryant CM, Carey T. Drug Class Review on Constipation Drugs. 2007. http://www.ohsu.edu/drugeffectiveness/reports/final.cfm ...
... Gartlehner G, Jonas DE, Morgan LC, Ringel Y, Hansen RA, Bryant CM, Carey T. Drug Class Review on Constipation Drugs. 2007. http://www.ohsu.edu/drugeffectiveness/reports/final.cfm ...
Outcome after tonsillectomy in adult patients with recurrent
... varied considerably between the patients (range −19 to +69). Only one patient reported declined QOL. The number of prior pharyngitis episodes, frequent throat pain, untreated dental caries and chronically infected tonsils were the best clinical factors predicting QOL improvement. The precision of th ...
... varied considerably between the patients (range −19 to +69). Only one patient reported declined QOL. The number of prior pharyngitis episodes, frequent throat pain, untreated dental caries and chronically infected tonsils were the best clinical factors predicting QOL improvement. The precision of th ...
Preotact, INN-parathyroid hormone (rdna)
... bisphosphonates, selective oestrogen receptor modulators and calcitonin). These drugs are effective in reducing bone turnover, as indicated by the changes in markers of both bone formation and resorption[1, 2]. The effect of these drugs on bone density is maximal during the first year, resulting in ...
... bisphosphonates, selective oestrogen receptor modulators and calcitonin). These drugs are effective in reducing bone turnover, as indicated by the changes in markers of both bone formation and resorption[1, 2]. The effect of these drugs on bone density is maximal during the first year, resulting in ...
prescribing information
... itching. If an allergic reaction to ofloxacin is suspected, stop the drug. Serious acute hypersensitivity reactions may require immediate emergency treatment. Oxygen and airway management, including intubation, should be administered as clinically indicated. ...
... itching. If an allergic reaction to ofloxacin is suspected, stop the drug. Serious acute hypersensitivity reactions may require immediate emergency treatment. Oxygen and airway management, including intubation, should be administered as clinically indicated. ...
Head Lice, American Academy of Pediatrics
... Food and Drug Administration (FDA) in April 2009 for treatment of head lice in children older than 6 months. The product is not neurotoxic to the lice, but kills them by asphyxiation. Phase III trials of this agent have included 2 randomized, multicenter, double-blind, vehicle-controlled trials and ...
... Food and Drug Administration (FDA) in April 2009 for treatment of head lice in children older than 6 months. The product is not neurotoxic to the lice, but kills them by asphyxiation. Phase III trials of this agent have included 2 randomized, multicenter, double-blind, vehicle-controlled trials and ...
Product information - Therapeutic Goods Administration
... and 10% lower for AUC) from those in men; however, there is no clinically significant difference in lipid effects with atorvastatin between men and women. Race There are no pharmacokinetic data on the co-administration of ezetimibe and atorvastatin in non-Caucasians. Ezetimibe Based on a meta-analys ...
... and 10% lower for AUC) from those in men; however, there is no clinically significant difference in lipid effects with atorvastatin between men and women. Race There are no pharmacokinetic data on the co-administration of ezetimibe and atorvastatin in non-Caucasians. Ezetimibe Based on a meta-analys ...
Pfizer Partnering Brochure
... approach to the development of new medicines for patients with rare diseases. We have a track record of creating innovative strategic partnerships with academic institutions, patient advocacy groups, and commercial enterprises to accelerate the development of novel therapeutics across the entire spe ...
... approach to the development of new medicines for patients with rare diseases. We have a track record of creating innovative strategic partnerships with academic institutions, patient advocacy groups, and commercial enterprises to accelerate the development of novel therapeutics across the entire spe ...
Porphyria Overview
... Hereditary coproporphyria results in most cases from half-normal activity (50%) of coproporphyrin oxidase.13 The disease is an acute hepatic porphyria that is characterized by abdominal pain, neuropsychiatric symptoms, and cutaneous photosensitivity14 In rare homozygous cases, enzyme activity decrea ...
... Hereditary coproporphyria results in most cases from half-normal activity (50%) of coproporphyrin oxidase.13 The disease is an acute hepatic porphyria that is characterized by abdominal pain, neuropsychiatric symptoms, and cutaneous photosensitivity14 In rare homozygous cases, enzyme activity decrea ...
Diagnosis and Management of Migraine, Tension
... frequent headache, the two may co-exist. In such cases, unless both conditions are recognised and dealt with individually, management is unlikely to be successful (see 10.0). ...
... frequent headache, the two may co-exist. In such cases, unless both conditions are recognised and dealt with individually, management is unlikely to be successful (see 10.0). ...
(BASH) guidelines (2010) - British Association for the Study of
... frequent headache, the two may co-exist. In such cases, unless both conditions are recognised and dealt with individually, management is unlikely to be successful (see 10.0). ...
... frequent headache, the two may co-exist. In such cases, unless both conditions are recognised and dealt with individually, management is unlikely to be successful (see 10.0). ...
spędzonym na wolnym powietrzu?
... Biorąc pod uwagę schematy dawkowania innych terapii przeciwko RZS (patrz tabela po prawej stronie), przyjmowanie leku Rituxan może oznaczać zmniejszanie z czasem częstotliwość podawania leku. W celu uzyskania informacji o bezpieczeństwie leku Rituxan, w tym możliwych reakcji na wlew, prosimy zapozna ...
... Biorąc pod uwagę schematy dawkowania innych terapii przeciwko RZS (patrz tabela po prawej stronie), przyjmowanie leku Rituxan może oznaczać zmniejszanie z czasem częstotliwość podawania leku. W celu uzyskania informacji o bezpieczeństwie leku Rituxan, w tym możliwych reakcji na wlew, prosimy zapozna ...
ACCF/AHA 2011 Expert Consensus Document on Hypertension in
... and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, and/or clinical p ...
... and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, and/or clinical p ...
product guide - Square Pharmaceuticals Ltd.
... (2.5 ml of syrup) 3 to 4 times a day. In motion sickness: Adults : 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg): 12.5 to 25 mg 3 to 4 times a day (5mg/ kg/ 24 hours). In parkinsonism: Adults: 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg) : 12.5 to 25 mg 3 to 4 times a day (5mg/ ...
... (2.5 ml of syrup) 3 to 4 times a day. In motion sickness: Adults : 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg): 12.5 to 25 mg 3 to 4 times a day (5mg/ kg/ 24 hours). In parkinsonism: Adults: 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg) : 12.5 to 25 mg 3 to 4 times a day (5mg/ ...
PRODUCT MONOGRAPH PrCIALIS
... use as needed for ED, diarrhea was reported more frequently in patients 65 years of age and older who were treated with CIALIS (2.5% of patients). Therefore no dose adjustment is warranted based on age alone. However, a greater sensitivity to medications in some older individuals should be considere ...
... use as needed for ED, diarrhea was reported more frequently in patients 65 years of age and older who were treated with CIALIS (2.5% of patients). Therefore no dose adjustment is warranted based on age alone. However, a greater sensitivity to medications in some older individuals should be considere ...
Adrenal Insufficiency: A Guide for Families
... referred as cortisol), mineralocorticoids (main hormone is aldosterone), and weak male hormones or androgens. Cortisol is a hormone that helps maintain blood vessel tone and blood sugar levels and is especially important in times of stress. Aldosterone controls salt balance in the body. Androgens ar ...
... referred as cortisol), mineralocorticoids (main hormone is aldosterone), and weak male hormones or androgens. Cortisol is a hormone that helps maintain blood vessel tone and blood sugar levels and is especially important in times of stress. Aldosterone controls salt balance in the body. Androgens ar ...
iarc monographs on the evaluation of carcinogenic risks to humans
... Topics are selected on the basis of two main criteria: (a) there is evidence of human exposure, and (b) there is some evidence or suspicion of carcinogenicity. The term ‘agent’ is used to include individual chemical compounds, groups of related chemical compounds, physical agents (such as radiation) ...
... Topics are selected on the basis of two main criteria: (a) there is evidence of human exposure, and (b) there is some evidence or suspicion of carcinogenicity. The term ‘agent’ is used to include individual chemical compounds, groups of related chemical compounds, physical agents (such as radiation) ...
Table of Contents
... controlled trial to assess the rate of decline of lung function with Spiriva HandiHaler in patients with COPD. Patients were enrolled with a diagnosis of moderate to severe COPD, with the following pertinent entry criteria: a) 40 years of age and older; b) FEV1/FVC ≤ 70% and FEV1 ≤ 70%; and c) curre ...
... controlled trial to assess the rate of decline of lung function with Spiriva HandiHaler in patients with COPD. Patients were enrolled with a diagnosis of moderate to severe COPD, with the following pertinent entry criteria: a) 40 years of age and older; b) FEV1/FVC ≤ 70% and FEV1 ≤ 70%; and c) curre ...
Glaucoma management - Maastricht University
... There is currently no medical intervention that can repair damaged retinal nerve fibers in a glaucomatous eye, so there is no cure for glaucoma. Instead, treatment of glaucoma is directed at lowering the intraocular pressure in order to slow down the neurodegenerative process. Likewise, pressure-low ...
... There is currently no medical intervention that can repair damaged retinal nerve fibers in a glaucomatous eye, so there is no cure for glaucoma. Instead, treatment of glaucoma is directed at lowering the intraocular pressure in order to slow down the neurodegenerative process. Likewise, pressure-low ...
Glaucoma - National Medical Research Council
... Secondary Glaucoma including the following major causes: a. Steroid-induced b. Uveitic c. Rubeotic d. Others ...
... Secondary Glaucoma including the following major causes: a. Steroid-induced b. Uveitic c. Rubeotic d. Others ...
In vitro Susceptibility of Helicobacter pylori to Licorice Extract
... the antibacterial spectrum of licorice is obviously confined to H. pylori and probably staphylococci (15). In contrast to the antibiotics used at present in the H. pylori regimens, it has the benefit of leaving the normal bacterial flora of the body unchanged and not selecting resistant bacteria. In ...
... the antibacterial spectrum of licorice is obviously confined to H. pylori and probably staphylococci (15). In contrast to the antibiotics used at present in the H. pylori regimens, it has the benefit of leaving the normal bacterial flora of the body unchanged and not selecting resistant bacteria. In ...
Aspects of thermoregulation physiology
... about the application and feasibility of therapeutic hypothermia. Many drugs have been tested in healthy volunteers and anaesthetized patients to abolish shivering but the best protocol for managing side-effects has not yet been defined. A possible strategy might be to simultaneously apply physical ...
... about the application and feasibility of therapeutic hypothermia. Many drugs have been tested in healthy volunteers and anaesthetized patients to abolish shivering but the best protocol for managing side-effects has not yet been defined. A possible strategy might be to simultaneously apply physical ...
PDF hosted at the Radboud Repository of the Radboud University Nijmegen
... analyse the outcome of patients with myocardial infarction according to their time to treatment. Boersma et al provided this analysis, publishing their reap11 praisal of the Golden Hour in 1996. In this, early treated patients from previous studies of prehospital thrombolysis were included so as to ...
... analyse the outcome of patients with myocardial infarction according to their time to treatment. Boersma et al provided this analysis, publishing their reap11 praisal of the Golden Hour in 1996. In this, early treated patients from previous studies of prehospital thrombolysis were included so as to ...
A Scientists Are Amazed at Progress of Alopecia Areata Treatment
... of Directors but have no medical or scientific background. I was a lay attendee at the meeting, so much that was said was way over my head! But here are a few of the many highlights I picked up at the meeting: ...
... of Directors but have no medical or scientific background. I was a lay attendee at the meeting, so much that was said was way over my head! But here are a few of the many highlights I picked up at the meeting: ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.